Pro Medicus Ltd. (PME) has reported a successful half-year with record-breaking financial achievements, including a substantial increase in revenue and profit after tax. The company has secured major contracts and completed implementations, and its Visage 7 product continues to dominate the market. Pro Medicus is focused on strategic growth, innovation, and expanding its footprint to deliver clinical and financial benefits to its clients. CEO Dr. Sam Hupert is optimistic about the company’s future and its commitment to advancing healthcare IT.
